Connect with us

Federal

Cannabis Could Be Rescheduled By Fall, Industry Insider Predicts

Published

4 months ago

on

Cannabis Could Be Rescheduled By Fall, Industry Insider Predicts

Two months after President Trump issuedexecutive orderhas directed his administration to move hemp from Schedule I to Schedule III, it remains unclear if that process is underway or when it might be completed. Meanwhile, the Food and Drug Administrationmissedthe deadline set by Congress for the publication of a list of known cannabinoids.

So where?hemp redevelopmentstand?

At stIgniteIt Market Spotlightt in New Jersey this month by cannabis industry executivesoffereddrastically different views of the timeline.

Moderator Jeff Guillot, CEO of Guillot Consulting, said he doesn’t expect the transfer plans to be finalized until the fall, citing little visible change since December and Attorney General Pam Bondi’s decision not to address the issue during recent congressional testimony.

To read the rest of this article on Green State, click here

Post An industry insider predicts that cannabis may be pushed to the fall first appeared on Marijuana Retail Report – News and information for cannabis retailers.

Related Topics:
Continue Reading

Federal

Marijuana Retail Report

Published

2 weeks ago

on

May 29, 2026

By

Marijuana Retail Report



Nebraska Attorney General Mike Hilgers had no immediate comment

The Republican attorneys general of Nebraska, Indiana and Louisiana filed a lawsuit over the Memorial Day weekend to stop Trump’s Justice Department order to reclassify marijuana as a less harmful drug.

The lawsuit, which the U.S. Court of Appeals for the District of Columbia Circuit has consolidated with a similar lawsuit by marijuana opponent Smart Approaches to Marijuana, alleges that the Trump administration bypassed its normal rulemaking process.

The AGs argue that the waiver of normal public notice and comment periods jeopardizes the validity of the changes and write that reclassifying marijuana could also violate the 1967 International Narcotics Control Treaty.

Nebraska Attorney General Mike Hilgers had no immediate comment through a spokesman Wednesday, but he said many Nebraska law enforcement officials disagree with the president’s push to change how federal agencies classify marijuana.

The lawsuit challenges the federal government’s workaround, which essentially makes it a middleman that buys the drug from manufacturers, adds a nominal fee, and sells it back to meet the contract’s requirements.

Hilgers argued that loosening federal restrictions on marijuana as a Schedule I drug, like LSD and heroin, to a Schedule III drug, along with Tylenol with codeine, could make it easier to legalize recreational products.

To read the rest of this article on the Nebraska Examiner, Click here

Continue Reading

Best Practices

Marijuana Retail Report

Published

1 month ago

on

May 6, 2026

By

Marijuana Retail Report



The DEA dispensary application portal is now live

For state-licensed medical marijuana operators, a narrow and potentially transformative window has opened that could position your business for future interstate and even global commerce.

While acting as the Prosecutor General rezoning order likely to face legal challenges, the immediate reality is that you have 60 days to act. As of yesterday, April 28, holders of state medical marijuana licenses can apply for DEA registration to manufacture (this includes cultivation and limited processing), distribute, and dispense medical marijuana.

DEA dispensary application portal is already operational and production and distribution applications are expected to comply with the standard DEA Form 225 Process.

We are not sure whether this framework would stand up to trialand if so, to what extent. However, it is clear that only those applicants who apply within this initial 60-day window are eligible for expedited review, which must take place within six months of application. The transfer order does not provide guidance on future application rounds or deadlines, leaving considerable uncertainty for those waiting.

In practical terms, this creates a first-mover advantage. If DEA registration ends up being the gateway to a federally recognized and possibly global market for medical cannabis, early applicants will have the best opportunity to participate.

We describe it as a “lottery ticket” not because it is speculative, but because it requires an upfront investment with uncertain outcomes. Retaining experienced counsel and preparing the relevant application typically costs in the range of $10,000 to $15,000 (including DEA fees), with additional costs depending on the complexity, scope and number of DEA filings required. The bet is $10,000 to $15,000 on a potential growth opportunity of hundreds of thousands or millions of dollars.

For those who are ready to move forward, we can help navigate the process effectively and strategically. Our team is one of the few with DEA ​​registration experience. We can:

  • Provide a clear overview of the DEA registration system and historical precedents
  • Prepare you for possible follow-up DEA inquiries and requests for additional information
  • Assistance in completing and submitting your application
  • Develop a comprehensive support package to strengthen your submission when the DEA seeks additional information
  • Advise on international treaty obligations and operational compliance considerations referenced by the order

If you plan to register with the DEA during this period, we encourage you to connect with our team to discuss your options. We are ready to provide you with a free consultation and help you evaluate whether this opportunity fits your business strategy.

Source: Legal Canna Blog

Continue Reading

CSA

The Biggest Things About Schedule III You Haven’t Thought Of

Published

1 month ago

on

April 29, 2026

By

The Biggest Things About Schedule III You Haven’t Thought Of

Brian Vicente, founding partner of influential Colorado law firm Vicente LLP, calls the suddenfederal move to move medical cannabis to Schedule III“the biggest thing to happen in federal cannabis policy in decades.”

In thisCannabis Business TimesIn the interview, Vicente breaks down three immediate consequences:

● potential section 280E tax relief for medical cannabis operators

● new DEA registration process for healthcare businesses

● and an expedited administrative hearing that could open the door to broader adult-use reform.

Vicente and his firm have worked on legalization policy in Colorado for decades and helped draft memos on the United Nations Single Convention on Narcotic Drugs, the international drug treaty that is at the heart of the Justice Department’s recent action.

He says state medical cannabis programs have been instrumental in providing federal officials with a basis for recognizing existing controls. He also sees major unsolved questions for states with hybrid medical and adult-use licenses, such as California, Maryland and Oregon, where businesses may need to determine how much of their operations qualifies as medical.

To read the rest of this article on Cannabis Business Times, Click here

Post The most important things about Schedule III you didn’t think about first appeared on Marijuana Retail Report – News and information for cannabis retailers.

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media